Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

TAZ/YAP fusion proteins: mechanistic insights and therapeutic opportunities

Trends in cancer(2022)10.1016/j.trecan.2022.08.002Source: DataRank Database

TAZ/YAP fusion proteins: mechanistic insights and therapeutic opportunities is a research paper published in Trends in cancer (2022). On theSindex it has a DataRank of 0. It has been cited 33 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access33 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (14 grants)OA: greenTopics (33)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Anne‐Claude Gingras ORCID,Kieran F. Harvey ORCID,Munir R. Tanas ORCID,Keith Garcia ORCID

Live enrichment

PubMed:36096997 PMC:PMC9671862

Canadian Institutes of Health Research

Grant: FDN 144301

National Health and Medical Research Council

Grant: APP1194467

National Cancer Institute

Grant: P30 CA086862

National Cancer Institute

Grant: 1 R01 CA237031-01A1S1

Health Services Research and Development

Grant: 1 I01 BX003644-01

BLRD VA

Grant: I01 BX003644

NCI NIH HHS

Grant: R01 CA237031

National Health and Medical Research Council (NHMRC)

Grant: 1194467

The Hippo pathway in development and cancer

Canadian Institutes of Health Research

Grant: unidentified

unidentified

National Institutes of Health

Grant: 1P30CA086862-01

Core--Clinical trials support group

National Institutes of Health

Grant: 5R01CA237031-04

Epigenetic modulation of the TAZ-CAMTA1 transcriptional program by the Ada2a-containing histone acetyltransferase complex

Veterans Health Administration Biomedical Laboratory Research and Development

National Institutes of Health

Terry Fox Research Institute

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9671862

publisherhttps://api.elsevier.com/content/article/PII:S240580332200173X?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S240580332200173X?httpAccept=text/plain

https://doi.org/10.1016/j.trecan.2022.08.002

https://pubmed.ncbi.nlm.nih.gov/36096997

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

HumansNeoplasmsIntracellular Signaling Peptides and ProteinsAdaptor Proteins, Signal TransducingTrans-ActivatorsPhosphoproteinsTranscription FactorsSignal TransductionYAP-Signaling ProteinsTranscriptional Coactivator with PDZ-Binding Motif ProteinsProtein Serine-Threonine Kinases

Keywords

Fusion proteinsYAPChromatin remodelingEpigeneticsTazTead Transcription Factors570Intracellular Signaling Peptides and Proteins610YAP-Signaling ProteinsProtein Serine-Threonine KinasesPhosphoproteinsTranscriptional Coactivator with PDZ-Binding Motif ProteinsNeoplasmsTrans-ActivatorsHumansAdaptor Proteins, Signal TransducingSignal TransductionTranscription Factors

Sustainable Development Goals

SDG 3: 3. Good health